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Objective: To determine predictors of Chlamydia trachomatis infection among women 14–24 years of age
attending family planning clinics throughout a rural Midwestern state.
Methods: The study population included 16 756 women between the ages of 14 and 24 years attending family
planning clinics for annual examinations throughout the state of Iowa in 1997. All women under 25 years of age
having annual exams were tested for C. trachomatis during the visit. At the time of exam, both behavioral and
demographic data were collected on all women participating in the study.
Results: The majority ofwomen inthestudy(96%) reportednosymptomsof chlamydia. Only2.5% ofallwomen
hadapositivetestresult.Inthe multivariate model,the oddsratiosweresignificantlyincreasedamongthe youngest
age (14–17 years; OR = 2.2), those with mucopurulent cervicitis (OR = 3.4), cervical friability (OR = 2.2),
symptomatic for infection (OR = 1.8), risk history (OR = 1.6), and black race (OR = 1.2) and predictive of a
C. trachomatis infection.
Conclusions: Risk factors predictive of C. trachomatis infection among younger aged women attending family
planning clinics in a Midwest rural population are consistent with predictors of infection among women attending
family planningclinicsacrosstheUnitedStates.The overallfindingssuggestthe importanceofdevelopingscreening
guidelines as a means of lowering chlamydia rates.This may be a particularly difficult task in light of the low rate of
symptoms that would lead a woman to seek medical care, even in younger age women who are at higher risk. In
addition, screening guidelines would be more difficult to implement in a rural setting.
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Genital infection resulting from Chlamydia
trachomatis remains the most prevalent sexually
transmitted bacterial infection in the United States
today, with an estimated 4 million cases occurring
every year1–7. Chlamydial infections have been
reported as being asymptomatic in up to 70% of
infected individuals, and may become problematic
when left untreated3,7,8. Sequelae that result from
untreated C. trachomatis infection include pelvic
inflammatory disease, ectopic pregnancy, chronic
pelvic pain and tubal infertility5,7,9–14. In addition,
conjunctivitisand pneumoniamay result in infants
born to mothers infected with C. trachomatis7.
Sequelae of C. trachomatis infections can be
extremely costly and may develop into further
health-threatening complications. In the United
States alone, costs related to chlamydia infection
have been estimated to reach as much as $2.4
billion annually15. As a result, screening programs
designed to identify both symptomatic and
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Clinical study 3asymptomatic individuals earlier in the course of
infectionarecrucialtothesuccessfultreatment and
control of C. trachomatis infections.
Much research has examined where screening
efforts should be focused. There has been a sub-
stantial amount of debate as to whether universal
screening or selective screening programs are
more effective4,6,11,13,15,16. Because the practice of
universalscreening isextremely costlyandmaynot
be necessary in populations where the prevalence
ofchlamydiainfection islow,manyprogramshave
developed screening criteria for select populations
which rely on targeting those individuals with risk
factors known to be predictive of infections.
Depending on the target population, some pro-
grams appear to be cost-effective in the detection
and treatment of infected individuals13.
Themain objectiveofthisstudywastoexamine
predictors of C. trachomatis infection among
women attending family planningclinics through-
out the rural state of Iowa. Furthermore, we
compared these predictors of chlamydia infection
seen in women to those residing in other
geographic locations in the United States. Using
the results of this study and others, we can suggest
populations of sexually active individuals in rural
Midwest communities where screening programs
shouldbetargeted andwhetherthis populationhas
different risks and health care screening needs to
that of other parts of the country.
SUBJECTS AND METHODS
Study population
The study population consisted of 16 756 women
between the ages of 14 and 24 years who were
attending family planning clinics throughout the
state of Iowa as part of the Centers for Disease
Control’s Region VII Infertility Prevention
Project. All women included in the study made an
annual visit to the clinics between January 1, 1997
and December 31, 1997.
Data collection
Behavioral and demographic data were collected
on all women screened for chlamydia using a
standardized form at each annual visit. Clinical
signs of infection included cervical friability,
mucopurulent cervicitis, cervicitis, and/or pelvic
inflammatory disease, and only one of these
needed to be present in order for the physician to
classify that individual as having clinical signs. As
part of the CDC screening project, all clinicians
were extensively trained at the beginning of the
project and then annually thereafter. The training
programs were augmented by a quality assurance
program and definitions of clinical characteristics
were standardized as part of the training and as
described in the project manual.
Cervical friability was defined as easily induced
bleeding with the initial swab during culture.
Yellow orgreen mucopurulentdischargefrom the
cervix, with infection, was classified as muco-
purulent cervicitis. Cervicitis was defined to
include any of the following: (1) edema, erythema
or follicle-like lesion in an area of ectopy (the
extension of columnar epithelium onto the
ectocervix); or(2)cervical mucuswithtenormore
polymorphonuclearleukocytes per ´ 1000 micro-
scopic level. Pelvic inflammatory disease was
defined as the findings of lower abdominal tender-
ness, adnexal tenderness, and cervical motion
tenderness in a patient complaining of pelvic pain.
Awomenwascharacterized ashavinga risk history
if any of the following was applicable: (1) multiple
sexual partners (two or more within 90 days)
and/or sexual partners with multiple partners,
(2) new sexual partner since last screening,
(3) contact with STD (symptomatic males, or
history of sex partner with symptoms of
chlamydia); or (4) request a test based on risk
history.Whetherornota patientwassymptomatic
(e.g. pelvic pain or vaginal discharge) was by
self-report.
Laboratory methods
Swab specimens were obtained from the patients
during their annual visits and were shipped to the
University of Iowa Hygienic Laboratory.
Processing occurred at the laboratory using the
SYVA Micro Trak II chlamydia EIA test.
Statistical analysis
Because the CDC screening criteria were applied
differently depending upon the age of the patient,
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youngeragedwomenonly(ages 14–24years). The
relationship between chlamydia infection and
potential risk factors or confounders were
examined and a test of association was obtained by
the Pearson’s c2 statistic, the Fischer’s Exact
two-sided test or the Mantel-Haenszel test as a
means of comparing categorical data in Tables 1
and 2. Odds ratios and 95% confidence intervals
were generated to determine statistical signif-
icance. Where p-values were calculated, results
were considered to be significant at values equalto
or less than 0.05.
Univariate logistic regression analysis using SAS
version 6.0 (SAS Institute Inc., Cary, NC) was
performed as a means of generating odds ratios to
assess the relationship between chlamydia
infection and each individual risk factor. Both
unadjusted and age-adjusted odds ratios
were calculated with their corresponding 95%
confidence intervals to determine significant
associations at the 5% level. Following univariate
logistic regression analysis, multivariate models
were generated for both age groups to determine
the best predictors of chlamydia infection.
RESULTS
There were 16 972 different patients aged 24 years
of age and younger who were classified as patients
attending family planning clinics annually
throughout the state of Iowa between January 1,
1997 and December 31, 1997. The mean age of
the women was 20.1 years and the racial
background was predominantly white (96.2%).
Overall, 95.6% of women had no symptoms of
an infection for chlamydia and only 2.5% of
women in this study tested positive regardless
of whether they reported symptoms or not.
Among those who were symptomatic for
chlamydia, over 7% tested positive compared to
only 2% of those without symptoms. A much
higher percentage of blacks compared to whites
had a positive test.
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Variable Category Total number Number positive % Positive p-value
Age group (years)
Clinical signs
Cervicitis
Mucopurulent cervicitis
Cervical friability
Risk history
Symptomatic
Race†
14–17
18–21
22–24
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Asian/Pacific Island
Black
Native American/Alaskan
White
Unknown
2577
9124
5040
1091
15 015
166
16 806
159
16 183
789
16 813
7920
8716
732
16 036
129
335
15
16 330
163
106
218
96
69
341
11
416
22
405
48
379
258
160
53
368
4
31
1
386
5
4.1
2.4
1.9
6.3
2.3
6.6
2.5
13.8
2.4
6.1
2.4
3.3
1.8
7.2
2.3
3.1
9.3
6.7
2.4
3.1
< 0.001
< 0.001
< 0.001*
< 0.001*
< 0.001
< 0.001
< 0.001
< 0.001
*p-Values are based on Pearson’sc
2 or Fischer’s Exact two-sided test when expected counts are less than 25;
†Referent: Caucasian
Table 1 Characteristics of women 24 years of age and younger attending family planningclinics throughout the State
of Iowa (n = 16 972)As shown in Table 1, 6.3% of the women pre-
sented with clinical signs of chlamydia infection.
The most commonly reported signs of those who
tested positive were mucopurulent cervicitis,
cervical friability, and cervicitis. This compares to
about only 2.5% of those without any of these
clinical signs who subsequently had a positive
chlamydia infection. Almost half of the women
had a history of sexual activity that placed them at
higher risk for chlamydia infection.
Multivariate logistic analyses examined risks of
infection, controlling for confounders and other
potential risks. Results indicated that in younger
aged women the following were predictive of
infection (Table 2): (1) the youngest age group
(14–17 years vs 22–24 years); (2) clinical signs of
cervicitis, mucopurulent cervicitis and cervical
friability, and (3) patient characteristics of
symptomatic, risk history, and race (black). The
strongest predictor of chlamydia infection was
mucopurulent cervicitis (adjusted OR = 3.4).
Cervical friability (OR = 2.2) and young age at
diagnosis, age 14–17 years (OR = 2.2), were also
associated with an increased risk of chlamydia
infection. Those aged 18–21 years did not have a
significantly increased risk over those aged 22–24
years. Although the ORs were elevated, the
presence of cervicitis did not significantly elevate
the risk of chlamydia. Infected women were more
likely to be symptomatic (OR = 1.8) than
uninfected women and to report a history of risky
sexual behavior (OR = 1.6). In addition, African-
American women had a significantly higher risk of
chlamydia infection compared to white women
(OR = 1.2).
DISCUSSION
The current study examined predictors of
infection in a rural Midwestern population of
young women screened for chlamydia. The
infection rate measured in this population was
similar to that reported in other studies, 2.5%
compared to 2.7–3.5% of women in family
planningand other types of clinical settings5,12, but
lower than in other reports3,17. Whether infection
rates are different by health care setting in this
rural population because access is more difficult
to obtain than it is among urban populations is
uncertain. At the time of this study there were no
active statewide screening programs for sexually
transmitted diseases or chlamydia specifically.
A major advantage of this study is that it utilized
one of the largest, multi-clinic database sources to
assess risks of infection, thus capturinga represent-
ative sample of the larger population. The results
confirm risk factors for C. trachomatis infection
foundin similar studies ofwomen attendingfamily
planning clinics in different geographic locations
of the United States. Other studies have also
confirmed cervical friability5,9,11, mucopurulent
cervicitis5,7,11, cervicitis7,9,13–15, the presence of
clinical signs of infection5,7,9,11,13, whether or not a
patient is symptomatic1, risk history, and race5,9 as
predictive of chlamydia infection.
Results from the multivariate analysis were also
consistent with those from other studies18-20
regarding age, namely that the youngest aged
women, 14–17 years, had the highest risk. In
contrast,thoseaged 18–21years had only a slightly
higher probability of infection compared to those
aged 22–24 years. Although it did not achieve
statistical significance, it would appear that
cervicitis was a clinically significant factor with the
risk elevated more than three-fold. Other studies
also have detected elevated rates of this clinical
characteristic in women with chlamydia21,22
.
Theanalysis wasrestricted tothosewomenwho
wereclassified aspresentingfortheirannualvisit to
the family planning clinic. The assumption was
that they were defined by theclinic record as visit-
ing the clinic one time during the study period for
their annual exam. If women had more than this
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Risk factor Odds ratio 95% CI
Age 14–17 years*
Age 18–21 years*
Cervicitis
Mucopurulent cervicitis
Cervical friability
Symptomatic
Risk history
Race (Black vs White)
2.23
1.24
3.42
3.42
2.16
1.84
1.56
1.24
(1.67, 2.98)
(0.97, 1.59)
(0.69, 2.87)
(2.01, 5.80)
(1.55, 3.02)
(1.29, 2.64)
(1.27, 1.91)
(1.05, 1.47)
*Compared to group aged 22–24 years
Table 2 Multivariate analysis of risk factors associated
with C. trachomatis infection in women£ 24 years of ageannual visit during the one-year study period, our
estimates may be biased depending on their
C. trachomatis infection status and the risk factors
they presented. However, women who were
suspected of having chlamydia infection during
their annual visit would be followed up in a differ-
ent clinic status category that was not included in
this analysis. Women who might have sought care
because of STD symptoms or other reasons, and
not for their annual visit were classified differently
and also were not included in the annual visit
group. Because our findings were generally
consistent with those of other studies, including
one other study in which patient identifiers were
unknown but showed risk factors similar to other
reports6, it is likely that potential misclassification
was limited.
One limitation of this study is the lack of racial
and ethnic diversity in the study population, since
themajorityofwomenresiding in theruralstate of
Iowa identify themselves as ‘white’. As a result,
some of our findings may not be generalizable to
populations with more diverse racial and ethnic
backgrounds. Nonetheless, there was a sufficient
African-American population to evaluate for risk
of infection. As found in other studies1,5, they
appear to be at higher risk of contracting
chlamydia. In contrast to this limitation, this
population is more characteristic of women for
whom access to routine health care is limited by
distance to a physician or clinic. It is important to
determine theprevalenceof chlamydiainthis rural
populationbecauseit islikely toindicatetheextent
of infection. In addition, it will show health care
providers and state and local health departments
the problems of providing adequate health care to
screen this high risk group.
This studyindicates thatamong women attend-
ing family planning clinics in a rural state who are
sexually active, present with symptoms or clinical
signs, a risky sexual history, younger age, or
black race are the most likely to be infected with
C. trachomatis. In light of these findings, chlamydia
control mechanisms should implement screening
programs that target these subgroups of individu-
als. With the high rates of infection, it is extremely
important to detect these cases early to reduce the
spread and adverse effects of this costly, but
preventable, sexually transmitted disease. Patients
may not only be asymptomatic but also may be
unawareoftheimplicationoftheirsymptoms until
theyaresufficientlysymptomatic tocreateconcern
on the woman’s part. Studies suggest that selective
screening is cost-effective when infection rates are
low, as foundin this population13. Such a program
that incorporates chlamydia screening as the
standard of care foryoung,sexually active women,
whether in public or private medical care settings,
would provide an important method to prevent
pelvic inflammatory disease, a major cause of
infertility and ectopic pregnancy. The difficulties
associated with rural health care among low
income women or those who live in an area with
limited health care access needs to be a priority of
rural health care providers and state governmental
funding. Such preventive programs could
provide a wide variety of early screening tests
simultaneously, while also administering to the
health educational needs of inexperienced women
and to maintain preventive benefits in this
high-risk population. These screening sites also
would provide a contactsource for continuedcare
and treatment information.
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